摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-2-Benzyloxycarbonylamino-3-cyclohexyl-propionic acid methyl ester | 113828-93-6

中文名称
——
中文别名
——
英文名称
(S)-2-Benzyloxycarbonylamino-3-cyclohexyl-propionic acid methyl ester
英文别名
Methyl (I+/-S)-I+/--[[(phenylmethoxy)carbonyl]amino]cyclohexanepropanoate;methyl (2S)-3-cyclohexyl-2-(phenylmethoxycarbonylamino)propanoate
(S)-2-Benzyloxycarbonylamino-3-cyclohexyl-propionic acid methyl ester化学式
CAS
113828-93-6
化学式
C18H25NO4
mdl
——
分子量
319.401
InChiKey
GPCBBYINDBESQY-INIZCTEOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    23
  • 可旋转键数:
    8
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    64.6
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Design, Synthesis, and Evaluation of Novel Prodrugs of Transition State Inhibitors of Norovirus 3CL Protease
    作者:Anushka C. Galasiti Kankanamalage、Yunjeong Kim、Athri D. Rathnayake、Kevin R. Alliston、Michelle M. Butler、Steven C. Cardinale、Terry L. Bowlin、William C. Groutas、Kyeong-Ok Chang
    DOI:10.1021/acs.jmedchem.7b00497
    日期:2017.7.27
    Ester and carbamate prodrugs of aldehyde bisulfite adduct inhibitors were synthesized in order to improve their pharmacokinetic and pharmacodynamic properties. The inhibitory activity of the compounds against norovirus 3C-like protease in enzyme and cell-based assays was determined. The ester and carbamate prodrugs displayed equivalent potency to those of the precursor aldehyde bisulfite adducts and
    醛亚硫酸氢盐加合物抑制剂的酯和氨基甲酸酯前药被合成,以改善其药代动力学和药效学性质。在酶和基于细胞的测定中,确定了化合物对诺如病毒3C样蛋白酶的抑制活性。酯和氨基甲酸酯前药显示出与前体醛亚硫酸氢盐加合物和前体醛相同的效力。此外,发现酯的裂解速率取决于烷基链长。产生的前药显示出低细胞毒性和令人满意的肝微粒体稳定性和血浆蛋白结合。
  • <i>Carica papaya</i>Lipase Catalysed Resolution of β-Amino Esters for the Highly Enantioselective Synthesis of (<i>S</i>)-Dapoxetine
    作者:Pengyong You、Jian Qiu、Erzheng Su、Dongzhi Wei
    DOI:10.1002/ejoc.201201055
    日期:2013.1
    CPL-catalysed resolution. The mechanism of the CPL-catalysed enantioselective alcoholoysis of the amino acids is discussed to delineate the substrate requirements for CPL-catalysed resolution. Finally, the reaction was scaled up, and the products were separated and obtained in good yields (≥ 80 %). The (S)-3-amino-3-phenylpropanoic acid obtained was used as a key chiral intermediate in the synthesis
    通过番木瓜脂肪酶 (CPL) 催化对映选择性醇解相应的外消旋 N 保护的 2,2,2-三氟乙酯在有机溶剂中的有效合成(S)-3-氨基-3-苯基丙酸对映​​体. 高对映选择性(E > 200)通过两种策略实现,涉及底物工程和反应条件的优化。基于一系列氨基酸的拆分,发现底物的结构对CPL催化的拆分具有深远的影响。通过将常规甲酯转换为活化的三氟乙酯,显着提高了对映选择性和反应速率。在考虑空间效应时,取代的苯基和氨基对于 CPL 催化的拆分不应都很大。讨论了 CPL 催化的氨基酸对映选择性醇解的机制,以描述 CPL 催化拆分的底物要求。最后,放大反应,分离产物并以良好的收率(≥ 80 %)获得。获得的 (S)-3-氨基-3-苯基丙酸用作合成 (S)-达泊西汀的关键手性中间体,对映体过量 (> 99 %)。
  • Inhibition of norovirus 3CL protease by bisulfite adducts of transition state inhibitors
    作者:Sivakoteswara Rao Mandadapu、Mallikarjuna Reddy Gunnam、Kok-Chuan Tiew、Roxanne Adeline Z. Uy、Allan M. Prior、Kevin R. Alliston、Duy H. Hua、Yunjeong Kim、Kyeong-Ok Chang、William C. Groutas
    DOI:10.1016/j.bmcl.2012.11.026
    日期:2013.1
    Noroviruses are the most common cause of acute viral gastroenteritis, accounting for >21 million cases annually in the US alone. Norovirus infections constitute an important health problem for which there are no specific antiviral therapeutics or vaccines. In this study, a series of bisulfite adducts derived from representative transition state inhibitors (dipeptidyl aldehydes and alpha-ketoamides) was synthesized and shown to exhibit anti-norovirus activity in a cell-based replicon system. The ED50 of the most effective inhibitor was 60 nM. This study demonstrates for the first time the utilization of bisulfite adducts of transition state inhibitors in the inhibition of norovirus 3C-like protease in vitro and in a cell-based replicon system. The approach described herein can be extended to the synthesis of the bisulfite adducts of other classes of transition state inhibitors of serine and cysteine proteases, such as alpha-ketoheterocycles and alpha-ketoesters. (C) 2012 Elsevier Ltd. All rights reserved.
  • Potent inhibition of norovirus by dipeptidyl α-hydroxyphosphonate transition state mimics
    作者:Sivakoteswara Rao Mandadapu、Mallikarjuna Reddy Gunnam、Anushka C. Galasiti Kankanamalage、Roxanne Adeline Z. Uy、Kevin R. Alliston、Gerald H. Lushington、Yunjeong Kim、Kyeong-Ok Chang、William C. Groutas
    DOI:10.1016/j.bmcl.2013.08.073
    日期:2013.11
    The design, synthesis, and evaluation of a series of dipeptidyl alpha-hydroxyphosphonates is reported. The synthesized compounds displayed high anti-norovirus activity in a cell-based replicon system, as well as high enzyme selectivity. (C) 2013 Elsevier Ltd. All rights reserved.
  • Structure-Guided Design and Optimization of Dipeptidyl Inhibitors of Norovirus 3CL Protease. Structure–Activity Relationships and Biochemical, X-ray Crystallographic, Cell-Based, and In Vivo Studies
    作者:Anushka C. Galasiti Kankanamalage、Yunjeong Kim、Pathum M. Weerawarna、Roxanne Adeline Z. Uy、Vishnu C. Damalanka、Sivakoteswara Rao Mandadapu、Kevin R. Alliston、Nurjahan Mehzabeen、Kevin P. Battaile、Scott Lovell、Kyeong-Ok Chang、William C. Groutas
    DOI:10.1021/jm5019934
    日期:2015.4.9
    Norovirus infection constitutes the primary cause of acute viral gastroenteritis. There are currently no vaccines or norovirus-specific antiviral therapeutics available for the management of norovirus infection. Norovirus 3C-like protease is essential for viral replication, consequently, inhibition of this enzyme is a fruitful avenue of investigation that may lead to the emergence of antinorovirus therapeutics. We describe herein the optimization of dipeptidyl inhibitors of norovirus 3C-like protease using iterative SAR, X-ray crystallographic, and enzyme and cell-based studies. We also demonstrate herein in vivo efficacy of an inhibitor using the murine model of norovirus infection.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物